Royalties for Licensed Products. GSK shall pay FivePrime royalties on a Calendar Quarterly basis, calculated on a Licensed Product-by-Licensed Product and country-by-country basis, as set forth in this Section 6.4.
Appears in 2 contracts
Samples: Collaboration and License Agreement (Five Prime Therapeutics Inc), Collaboration and License Agreement (Five Prime Therapeutics Inc)
Royalties for Licensed Products. GSK shall pay FivePrime royalties on a Calendar Quarterly basis, calculated on a Licensed Product-by-Licensed Product and country-by-country basis, as set forth in this Section 6.4. For clarity, Licensed Products for each Committed Lead Target generated pursuant to any Expanded Research Program for Muscle Diseases, *** and/or Other Indication shall be subject to the same royalty payment obligations as Licensed Products for the Committed Lead Target generated pursuant to the Initial Research Program.
Appears in 2 contracts
Samples: And License Agreement (Five Prime Therapeutics Inc), And License Agreement (Five Prime Therapeutics Inc)
